FLR
59
3
KSS
59
5
PVH
58
4
CHRW
53
2
KHC
56
6
HPQ
63
-7
SCHW
49
4
OKE
67
2
QCOM
57
-2
IR
74
3
NWSA
58
4
AA
61
-2
UHS
59
-8
QRVO
47
-5
KLAC
63
-5
CL
62
3
FMC
40
-10
LH
46
-2
SRE
56
7
RCL
77
-4
FLR
59
3
KSS
59
5
PVH
58
4
CHRW
53
2
KHC
56
6
HPQ
63
-7
SCHW
49
4
OKE
67
2
QCOM
57
-2
IR
74
3
NWSA
58
4
AA
61
-2
UHS
59
-8
QRVO
47
-5
KLAC
63
-5
CL
62
3
FMC
40
-10
LH
46
-2
SRE
56
7
RCL
77
-4
Financhill
Back

The Arena Group Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
5

AREN
The Arena Group Holdings

Last Price:
0.73
Seasonality Move:
33.7%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
54.41
Seasonality Move:
7.55%
Sell
5
The Arena Group Holdings (AREN) is a Sell

Is The Arena Group Holdings a Buy, Sell or Hold?

  • The current The Arena Group Holdings [AREN] share price is $0.75. The Score for AREN is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • AREN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AREN Stock Price Chart

What is The Arena Group Holdings's stock price today?

  • The The Arena Group Holdings share price today is $0.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AREN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.43
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

AREN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 40.66 Sell
Chaikin Money Flow: 25317 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.8 - 0.94) Sell
Bollinger Bands (100): (0.8 - 0.92) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 43.18 Sell
Chaikin Money Flow: -435004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.76 - 58.26) Sell
Bollinger Bands (100): (40.14 - 54.08) Buy

AREN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.79 Sell
20-day SMA: 0.86 Sell
50-day SMA: 0.88 Sell
200-day SMA: 1.14 Sell
8-day EMA: 0.79 Sell
20-day EMA: 0.83 Sell
50-day EMA: 0.86 Sell
200-day EMA: 1.5 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.08 Sell
20-day SMA: 56.96 Sell
50-day SMA: 52.99 Buy
200-day SMA: 46.88 Buy
8-day EMA: 56.5 Sell
20-day EMA: 56.46 Sell
50-day EMA: 53.4 Buy
200-day EMA: 47.32 Buy

The Arena Group Holdings Earnings Growth & AREN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

The Arena Group Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):